Clinical Efficacy of Crizotinib in Advanced ALK Positive 
Non-small Cell Lung Cancer

Clinical Efficacy of Crizotinib in Advanced ALK Positive 
Non-small Cell Lung Cancer

Background and objective The aim of this study is to explore clinical efficacy of crizotinib in advanced anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer. Methods Twenty-eight patients with advanced non-small cell lung cancer habouring ALK positive were randomly divided into criz...

Full description

Bibliographic Details
Main Authors: Jing ZHAO, Kun ZHANG, Liyu ZHANG, Hong WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Crizotinib
Docetaxel
ALK
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.10.03

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2015.10.03

Similar Items